Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-01-03 @ 10:58 PM
Study NCT ID:
NCT00259818
Status:
COMPLETED
Last Update Posted:
2008-01-24
First Post:
2005-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
Sponsor:
Erimos Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EM-1421 #101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None